Level Chart

Basic Info

Eli Lilly & Co (LLY) - Immunology Revenue is at a current level of 1.104B, up from 986.90M last quarter and up from 933.60M one year ago. This is a change of 11.91% from last quarter and 18.29% from one year ago.

Immunology Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to immunology within a specific reporting period.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 1.104B
Latest Period Dec 2023
Last Updated Feb 29 2024, 08:53 EST
Next Release May 31 2024, 08:30 EDT (E)
Average Growth Rate 30.88%
Value from Last Quarter 986.90M
Change from Last Quarter 11.91%
Value from 1 Year Ago 933.60M
Change from 1 Year Ago 18.29%
Frequency Quarterly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
December 31, 2023 1.104B
September 30, 2023 986.90M
June 30, 2023 928.50M
March 31, 2023 777.80M
December 31, 2022 933.60M
September 30, 2022 866.40M
June 30, 2022 796.50M
March 31, 2022 748.10M
December 31, 2021 956.60M
Date Value
September 30, 2021 1.005B
June 30, 2021 785.50M
March 31, 2021 613.90M
December 31, 2020 700.70M
September 30, 2020 627.10M
June 30, 2020 548.30M
March 31, 2020 585.80M
December 31, 2019 409.50M

Basic Info

Eli Lilly & Co (LLY) - Immunology Revenue is at a current level of 1.104B, up from 986.90M last quarter and up from 933.60M one year ago. This is a change of 11.91% from last quarter and 18.29% from one year ago.

Immunology Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to immunology within a specific reporting period.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 1.104B
Latest Period Dec 2023
Last Updated Feb 29 2024, 08:53 EST
Next Release May 31 2024, 08:30 EDT (E)
Average Growth Rate 30.88%
Value from Last Quarter 986.90M
Change from Last Quarter 11.91%
Value from 1 Year Ago 933.60M
Change from 1 Year Ago 18.29%
Frequency Quarterly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
LLY Eli Lilly and Co -2.77%